Bettina Huber

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Esophageal papillomas and human papillomavirus infection: A case series, scoping review and analysis.

Esophageal papillomas and human papillomavirus infection: A case series, scoping review and analysis.

Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: January 16, 2026

The Controversial Link Between Human Papillomavirus Infection and Esophageal Health: An Exploratory Translational Study.

The Controversial Link Between Human Papillomavirus Infection and Esophageal Health: An Exploratory Translational Study.

Journal: Pathogens (Basel, Switzerland)
Published: December 18, 2025

LTβR deficiency causes lymph node aplasia and impaired B cell differentiation.

LTβR deficiency causes lymph node aplasia and impaired B cell differentiation.

Journal: Science immunology
Published: November 22, 2024

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development.

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development.

Journal: Frontiers in immunology
Published: August 03, 2022

Polymerase-δ-deficiency as a novel cause of inborn cancer predisposition associated with human papillomavirus infection.

Polymerase-δ-deficiency as a novel cause of inborn cancer predisposition associated with human papillomavirus infection.

Journal: The British journal of dermatology
Published: July 29, 2022

RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer.

RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer.

Journal: Journal of virology
Published: June 15, 2022

RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates.

RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates.

Journal: Journal of clinical medicine
Published: February 14, 2021

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV).

Journal: PloS one
Published: October 17, 2016

Correction: Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.

Correction: Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.

Journal: PloS one
Published: November 13, 2015

Establishment of an in vitro equine papillomavirus type 2 (EcPV2) neutralization assay and a VLP-based vaccine for protection of equids against EcPV2-associated genital tumors.

Establishment of an in vitro equine papillomavirus type 2 (EcPV2) neutralization assay and a VLP-based vaccine for protection of equids against EcPV2-associated genital tumors.

Journal: Virology
Published: May 04, 2015

Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.

Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach.

Journal: PloS one
Published: April 22, 2015

A chimeric 18L1-45RG1 virus-like particle vaccine cross-protects against oncogenic alpha-7 human papillomavirus types.

A chimeric 18L1-45RG1 virus-like particle vaccine cross-protects against oncogenic alpha-7 human papillomavirus types.

Journal: PloS one
Published: September 24, 2014
Showing 1-12 of 13

Last Updated: 09/26/2026